tag:blogger.com,1999:blog-19490962.post554157020045593360..comments2023-12-10T10:06:41.979+00:00Comments on mutations of mortality: Signaling: negative regulators of PTKsTerry Hamblinhttp://www.blogger.com/profile/06346629921055055879noreply@blogger.comBlogger2125tag:blogger.com,1999:blog-19490962.post-37679473030023811772011-07-23T10:10:02.904+01:002011-07-23T10:10:02.904+01:00It is complicated. The answer is probably a mixtur...It is complicated. The answer is probably a mixture of inhibitors.Terry Hamblinhttps://www.blogger.com/profile/06346629921055055879noreply@blogger.comtag:blogger.com,1999:blog-19490962.post-22697059986449985052011-07-23T07:19:35.479+01:002011-07-23T07:19:35.479+01:00Terry,
It is all so complicated. It seems extraord...Terry,<br />It is all so complicated. It seems extraordinary to me that this often indolent blood cancer has so many signaling pathways that are amuck. The more I read on new understanding of many ways normal cellular function is messed up in the CLL lymphocyte, the less hopeful I become that a Gleevec type solution is possible for this cancer.<br />Am I right to despair that a targeted therapy for CLL is not near at hand?<br />Be well<br />BrianBrian Koffmanhttps://www.blogger.com/profile/13250684684103918493noreply@blogger.com